NCT05483855 Telehealth-delivered HealthcaRe to ImproVe Care
| NCT ID | NCT05483855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Attune Health Research, Inc. |
| Condition | Telemedicine |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,580 participants |
| Start Date | 2023-01-03 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,580 participants in total. It began in 2023-01-03 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment examinations to observe and report the number of tender and swollen joint counts.
Eligibility Criteria
Inclusion Criteria: * Must be 19 years or older. * Must have a prior diagnosis of Rheumatoid Arthritis. * Must be able to read and write in English or Spanish. Exclusion Criteria: * Younger than 19 years of age * Does not have a prior diagnosis of Rheumatoid Arthritis. * Unable to read and write in English or Spanish
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05483855 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Telemedicine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05483855 currently recruiting?
Yes, NCT05483855 is actively recruiting participants. Contact the research team at research.admin@attunehealth.com for enrollment information.
Where is the NCT05483855 trial being conducted?
This trial is being conducted at Beverly Hills, United States.
Who is sponsoring the NCT05483855 clinical trial?
NCT05483855 is sponsored by Attune Health Research, Inc.. The trial plans to enroll 1,580 participants.